These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34246719)

  • 1. Antitumoral synergism between a copper(II) complex and cisplatin improves in vitro and in vivo anticancer activity against melanoma, lung and breast cancer cells.
    Mariani D; Ghasemishahrestani Z; Freitas W; Pezzuto P; Costa-da-Silva AC; Tanuri A; Kanashiro MM; Fernandes C; Horn A; Pereira MD
    Biochim Biophys Acta Gen Subj; 2021 Oct; 1865(10):129963. PubMed ID: 34246719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper(ii) complexes with tridentate halogen-substituted Schiff base ligands: synthesis, crystal structures and investigating the effect of halogenation, leaving groups and ligand flexibility on antiproliferative activities.
    Kordestani N; Amiri Rudbari H; Fernandes AR; Raposo LR; Luz A; Baptista PV; Bruno G; Scopelliti R; Fateminia Z; Micale N; Tumanov N; Wouters J; Abbasi Kajani A; Bordbar AK
    Dalton Trans; 2021 Mar; 50(11):3990-4007. PubMed ID: 33650599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the hydroxamate group in the antitumoral activity and toxicity toward normal cells of new copper(II) complexes.
    Azeredo NFB; Borges FV; Mathias MS; Resende JALC; Franco RWA; Kanashiro MM; Horn A; Fernandes C
    Biometals; 2021 Apr; 34(2):229-244. PubMed ID: 33559811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New manganese(II), iron(II), cobalt(II), nickel(II) and copper(II) saccharinate complexes of 2,6-bis(2-benzimidazolyl)pyridine as potential anticancer agents.
    Icsel C; Yilmaz VT; Aydinlik Ş; Aygun M
    Eur J Med Chem; 2020 Sep; 202():112535. PubMed ID: 32653697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of apoptosis in leukemia cell lines by new copper(II) complexes containing naphthyl groups via interaction with death receptors.
    Fernandes C; Horn A; Lopes BF; Bull ES; Azeredo NFB; Kanashiro MM; Borges FV; Bortoluzzi AJ; Szpoganicz B; Pires AB; Franco RWA; Almeida JCA; Maciel LLF; Resende JALC; Schenk G
    J Inorg Biochem; 2015 Dec; 153():68-87. PubMed ID: 26485179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Square planar Au(III), Pt(II) and Cu(II) complexes with quinoline-substituted 2,2':6',2″-terpyridine ligands: From in vitro to in vivo biological properties.
    Choroba K; Machura B; Szlapa-Kula A; Malecki JG; Raposo L; Roma-Rodrigues C; Cordeiro S; Baptista PV; Fernandes AR
    Eur J Med Chem; 2021 Jun; 218():113404. PubMed ID: 33823390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiosemicarbazone(s)-anchored water soluble mono- and bimetallic Cu(ii) complexes: enzyme-like activities, biomolecular interactions, anticancer property and real-time live cytotoxicity.
    Balakrishnan N; Haribabu J; Dhanabalan AK; Swaminathan S; Sun S; Dibwe DF; Bhuvanesh N; Awale S; Karvembu R
    Dalton Trans; 2020 Jul; 49(27):9411-9424. PubMed ID: 32589180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, DNA binding, antibacterial and anticancer properties of two novel water-soluble copper(II) complexes containing gluconate.
    Cai DH; Zhang CL; Liu QY; He L; Liu YJ; Xiong YH; Le XY
    Eur J Med Chem; 2021 Mar; 213():113182. PubMed ID: 33486198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo studies of the antineoplastic activity of copper (II) compounds against human leukemia THP-1 and murine melanoma B16-F10 cell lines.
    Borges LJH; Bull ÉS; Fernandes C; Horn A; Azeredo NF; Resende JALC; Freitas WR; Carvalho ECQ; Lemos LS; Jerdy H; Kanashiro MM
    Eur J Med Chem; 2016 Nov; 123():128-140. PubMed ID: 27474929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitroimidazole and glucosamine conjugated heteroscorpionate ligands and related copper(II) complexes. Syntheses, biological activity and XAS studies.
    Pellei M; Papini G; Trasatti A; Giorgetti M; Tonelli D; Minicucci M; Marzano C; Gandin V; Aquilanti G; Dolmella A; Santini C
    Dalton Trans; 2011 Oct; 40(38):9877-88. PubMed ID: 21709917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo antiproliferative activity on lung cancer of two acylhydrazone based zinc(II) complexes.
    Chang Q; Xie Y; Lu X; Zong Z; Zhang E; Cao S; Liang L
    Bioorg Chem; 2024 Jun; 147():107422. PubMed ID: 38705106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Pt(IV) complexes containing salvigenin ligand reverse cisplatin-induced resistance by inhibiting Rap1b-mediated cancer cell stemness in esophageal squamous cell carcinoma treatments.
    Zhao J; Wu K; Yang Y; Liu D; Zhang C; Li X
    Bioorg Chem; 2024 Jun; 147():107384. PubMed ID: 38643568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiosemicarbazone Mixed-Valence Cu(I/II) Complex against Lung Adenocarcinoma Cells through Multiple Pathways Involving Cuproptosis.
    Li A; Huang K; Pan W; Wu Y; Liang Y; Zhang Z; Wu D; Ma L; Gou Y
    J Med Chem; 2024 Jun; 67(11):9091-9103. PubMed ID: 38778566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin and photodynamic therapy exert synergistic inhibitory effects on small-cell lung cancer cell viability and xenograft tumor growth.
    Cheng YS; Peng YB; Yao M; Teng JP; Ni D; Zhu ZJ; Zhuang BF; Yang ZY
    Biochem Biophys Res Commun; 2017 Jun; 487(3):567-572. PubMed ID: 28431928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed copper-platinum complex formation could explain synergistic antiproliferative effect exhibited by binary mixtures of cisplatin and copper-1,10-phenanthroline compounds: An ESI-MS study.
    Pivetta T; Lallai V; Valletta E; Trudu F; Isaia F; Perra D; Pinna E; Pani A
    J Inorg Biochem; 2015 Oct; 151():107-14. PubMed ID: 26021964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Octahedral copper(ii)-diimine complexes of triethylenetetramine: effect of stereochemical fluxionality and ligand hydrophobicity on Cu
    Sharma M; Ganeshpandian M; Majumder M; Tamilarasan A; Sharma M; Mukhopadhyay R; Islam NS; Palaniandavar M
    Dalton Trans; 2020 Jun; 49(24):8282-8297. PubMed ID: 32510543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dinuclear orthometallated gold(I)-gold(III) anticancer complexes with potent in vivo activity through an ROS-dependent mechanism.
    Mirzadeh N; Telukutla SR; Luwor R; Privér S; Velma GR; Jakku RK; Andrew N S; Plebanski M; Christian H; Bhargava S
    Metallomics; 2021 Jul; 13(7):. PubMed ID: 34165566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platinum(IV) complexes conjugated with chalcone analogs as dual targeting anticancer agents: In vitro and in vivo studies.
    Huang X; Liu Z; Wang M; Yin X; Wang Y; Dai L; Wang H
    Bioorg Chem; 2020 Dec; 105():104430. PubMed ID: 33171407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Terpyridine copper(II) complexes as potential anticancer agents by inhibiting cell proliferation, blocking the cell cycle and inducing apoptosis in BEL-7402 cells.
    Gu YQ; Zhong YJ; Hu MQ; Li HQ; Yang K; Dong Q; Liang H; Chen ZF
    Dalton Trans; 2022 Feb; 51(5):1968-1978. PubMed ID: 35023532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of pyrrolizines and their Cu(II) complexes: Design, synthesis and cytotoxic screening with potential apoptosis-inducing activity.
    Gouda AM; El-Ghamry HA; Bawazeer TM; Farghaly TA; Abdalla AN; Aslam A
    Eur J Med Chem; 2018 Feb; 145():350-359. PubMed ID: 29335201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.